Transdermal administration of olanzapine

Details Transdermal administration of olanzapine Transdermal administration of olanzapine

1995-09-14

1999-04-06

Phelan, D. Gabrielle

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Web, sheet or filament bases; compositions of bandages; or...

424448, A61F 1300

Patent

active

058914617

ABSTRACT:
Transdermal administration of olanzapine and pharmaceutically acceptable acid addition salts thereof is described. The method involves treating an individual suffering from or susceptible to psychosis, acute mania or mild anxiety states, particularly those afflicted with schizophrenia or schizophreniform illnesses, by administering olanzapine or a salt thereof through the skin or mucosal tissue, for a time period and at an administration rate effective to alleviate the symptoms of the disease. Pharmaceutical formulations and drug delivery systems for administering olanzapine are provided as well.

REFERENCES:
patent: 4220152 (1980-09-01), Dresback
patent: 4379454 (1983-04-01), Campbell et al.
patent: 4412036 (1983-10-01), Pedersen et al.
patent: 4438258 (1984-03-01), Graham
patent: 4467012 (1984-08-01), Pedersen et al.
patent: 4644033 (1987-02-01), Gnanou et al.
patent: 4698062 (1987-10-01), Gale et al.
patent: 4731391 (1988-03-01), Garvey
patent: 4849224 (1989-07-01), Chang et al.
patent: 4915950 (1990-04-01), Miranda et al.
patent: 4985467 (1991-01-01), Kelly et al.
patent: 5000955 (1991-03-01), Gould et al.
patent: 5120546 (1992-06-01), Hansen et al.
patent: 5160328 (1992-11-01), Cartmell et al.
patent: 5203768 (1993-04-01), Haak et al.
patent: 5216098 (1993-06-01), Almed et al.
patent: 5225198 (1993-07-01), Sharma
patent: 5229382 (1993-07-01), Chakrabarti et al.
patent: 5352508 (1994-10-01), Cheong
patent: 5423737 (1995-06-01), Cartmell et al.
patent: 5457101 (1995-10-01), Greenwood et al.
patent: 5464628 (1995-11-01), Jalonen
patent: 5503843 (1996-04-01), Santus et al.
patent: 5605897 (1997-02-01), Beasley, Jr.
Chen et al. (1985), "Synthetic and natural polymers," Absorbency Ch. VI:197-216.
Fuller et al., "Neuroendocrine Evidence for Antagonism of Serotonin and Dopamine Receptors by Olanzapine (LY170053), an Antipsychotic Drug Candidate," Research Communications in Chemical Pathology and Pharmacology 77(1):87-93 (1992).
Moore et al., "The Behavioral Pharmacology of Olanzapine, a Novel `Atypical` Antipsychotic Agent," Journal of Pharmacology and Experimental Therapeutics 262(2):545-551 (1992).
Tran et al., "Clinical Efficacy and Safety of Olanzapine, A New Atypical Antipsychotic Agent," Neuropsychopharmacology 10(3S), Part 2 (1994).

Affiliated with

Also associated with

Rating

Transdermal administration of olanzapine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal administration of olanzapine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal administration of olanzapine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1368780